Search details
1.
A randomized study of the safety and pharmacokinetics of GSK3358699, a mononuclear myeloid-targeted bromodomain and extra-terminal domain inhibitor.
Br J Clin Pharmacol
; 88(5): 2140-2155, 2022 05.
Article
in English
| MEDLINE | ID: mdl-34773923
Results
1 -
1
de 1
1
Next >
>>